Amanote Research

Amanote Research

    RegisterSign In

Bugs as Cancer Drugs, Challenges and Opportunities

Molecular and Cellular Biology - United States
doi 10.1128/mcb.00206-19
Full Text
Open PDF
Abstract

Available in full text

Categories
Cell BiologyMolecular Biology
Date

May 13, 2019

Authors
Phillip J. DaschnerAvraham RasoolyJeffrey D. White
Publisher

American Society for Microbiology


Related search

Neoepitopes as Cancer Immunotherapy Targets: Key Challenges and Opportunities

Immunotherapy
OncologyAllergyImmunology
2017English

Lung Cancer: Future Challenges and Opportunities

Journal of Pulmonary & Respiratory Medicine
2013English

How Bugs Kill Bugs: Progress and Challenges in Bacteriocin Research

Biochemical Society Transactions
Biochemistry
2012English

Bugs as Drugs: Therapeutic Microbes for the Prevention and Treatment of Disease

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2019English

Psychiatry as a Medical Specialty: Challenges and Opportunities

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2010English

Immunotherapy and Pancreatic Cancer: Unique Challenges and Potential Opportunities

Therapeutic Advances in Medical Oncology
Oncology
2018English

Challenges and Opportunities

Teaching Exceptional Children
DevelopmentalEducationEducational Psychology
2016English

Historical Biobanks in Breast Cancer Metabolomics— Challenges and Opportunities

Metabolites
BiochemistryEndocrinologyMetabolismMolecular BiologyDiabetes
2019English

Challenges and Opportunities

Science
MultidisciplinaryPhilosophy of ScienceHistory
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy